About the Company

Grail develops a pan-cancer screening test designed to detect cancers at an early stage.

Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection.

The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.

Company Overview
Job alerts

Subscribe to our weekly job alerts below and never miss the latest jobs

Sign in

Sign Up

Forgotten Password

Job Quick Search